Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Repurposing Existing Drugs
Dr. Heather Ferris: This is Your Brain on Ozempic
Despite New Spin, Obesity and Diabetes Drug Failed Alzheimer’s Trial
Why the ADDF Is Betting $5M on This Experimental Alzheimer’s Drug
Why Are Alzheimer’s Drugs So Slow to Come? A Pharmacy Expert Explains
Can Viagra Treat Dementia? Clinical Pharmacists Call ‘69%’ Finding Into Question
Viagra May Cut Dementia Risk—But Don’t Get Too Excited
ADHD Drugs for Alzheimer’s Apathy?
Two FDA-Approved Drugs May Help Treat Alzheimer’s Symptoms
Seizures and Alzheimer’s: An Anti-Seizure Drug May Benefit Memory, Too
Approved “Water Pill” Bumetanide May Reduce Alzheimer’s Risk
Can Nicotine Patches Snuff Out Mild Cognitive Impairment? Clinical Trial Underway
‘Cautiously Optimistic:’ Cancer Drug Sargramostim May Improve Memory in Alzheimer’s
Alzheimer’s Drugs Worth Repurposing?
Pimavanserin Snag: FDA Rejects Acadia’s Dementia Psychosis Drug
Could Arthritis Drug Olumiant Treat Alzheimer’s? A.I. Thinks So
1
2
Next
Page load link
Go to Top